Welcome to our dedicated page for WW International news (Ticker: WW), a resource for investors and traders seeking the latest updates and insights on WW International stock.
WW International, Inc. operates the Weight Watchers weight-management platform through digital, workshop and clinical subscription offerings. Company news commonly covers subscriber trends, subscription revenue, adjusted operating measures and the balance between its Behavioral business and its Clinical business.
Recurring updates also include expansion of the Med+ clinical offering, access to FDA-approved GLP-1 treatment options through affiliated medical groups, debt-reduction actions involving its term loan, and governance changes such as board appointments, committee assignments and interim executive-leadership structure.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
WW International, Inc. (NASDAQ: WW) will announce its first quarter 2023 results on May 4, 2023, after market close. A conference call will follow at 5:00 p.m. ET, featuring CEO Sima Sistani and Interim Principal Financial Officer Heather Stark discussing the results and responding to investor queries.
The call will be accessible via a live webcast on the Company's corporate website, with supplemental materials made available beforehand. A replay of the webcast will be accessible for approximately 90 days.
WW International (NASDAQ: WW) has successfully acquired Weekend Health, Inc., a telehealth platform focused on chronic weight management. This acquisition aims to enhance WW's capabilities by integrating medication management and clinical care, aligning with the company's strategy to expand its market presence. WW's CEO, Sima Sistani, emphasized the importance of integrating clinical interventions for individuals qualified for medication. This step is expected to provide sustainable, science-backed weight health solutions, acknowledging the advancements in chronic weight management medications.